US Patent Issued to HEALIOS, THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM on Sept. 1 for "Modulation of splenocytes in cell therapy" (Ohio, Texas Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. RE51,018, issued on Sept. 1, was assigned to HEALIOS K.K. (Japan) and THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Modulation of splenocytes in cell therapy" was invented by Robert W. Mays (Shaker Heights, Ohio) and Charles S. Cox Jr. (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods for treating pathological conditions associated with an undesirable inflammatory component. The invention is generally directed to reducing inflammation by administering cells that have one or more of the following effects in an injured subject: interact with splenocytes, preserve splenic mass, increase prolifera...